Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Dec;127(12):1313-1321.
doi: 10.1007/s11547-022-01536-y. Epub 2022 Sep 27.

Endovascular treatment of cesarean scar pregnancy: a retrospective multicentric study

Affiliations
Multicenter Study

Endovascular treatment of cesarean scar pregnancy: a retrospective multicentric study

Giovanni Failla et al. Radiol Med. 2022 Dec.

Abstract

Purpose: To assess the role of Uterine Artery Embolization (UAE) to treat cesarean scar pregnancy (CSP) using different embolic materials, focusing on its clinical and technical success rates; the association of UAE with methotrexate (MTX) and/or dilatation & curettage (D&C) was evaluated also.

Materials and methods: A retrospective analysis 33 patients (mean age 35 years) affected by CSP and treated with UAE from March 2012 to 2020 was performed. Dynamic levels of serum β-HCG have been collected until they decreased to normal values after procedures. For the statistical analysis the sample was divided into 2 groups: UAE versus UAE + MTX.

Results: The gestational sac age ranged between 5 and 13 weeks (mean 7 weeks). According to operator's preference, 11 patients (33.33%) were treated with sponge injection, 2 patients (6.06%) with a combination of sponge and microsphere the remaining 20 patients (60.60%) with microspheres alone. No major complications occurred after UAE and D&C, neither side effects related to the MTX administration. Technical and clinical success rates were 97% and 85%, respectively. Mean percentage of β-HCG reduction was 90% (range - 99.92 to + 7.98%). Statistical analysis with linear regression shows a R2 value of 0.9624 in UAE group while a R2 value of 0.9440 in UAE + MTX group with statistical significance (p < 0.0001). No significative differences were found between the two groups about clinical success rate and embolic material adopted.

Conclusion: In this series UAE has been found to be safe and effective for the treatment of CSP.

Keywords: Angiography; Dilation and curettage; Ectopic pregnancy; Scar pregnacy; Ultrasound; Uterine artery embolization.

PubMed Disclaimer

References

    1. Petersen KB, Hoffmann E, Larsen CR, Nielsen HS (2016) Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril 105(4):958–967. https://doi.org/10.1016/j.fertnstert.2015.12.130 - DOI
    1. Grechukhina O, Deshmukh U, Fan L, Kohari K et al (2018) Cesarean Scar Pregnancy, Incidence, and Recurrence. Obstet Gynecol 132:1285–1295 - DOI
    1. Elmokadem AH, Abdel-Wahab RM, El-Zayadi AA et al (2019) Uterine artery embolization and methotrexate infusion as sole management for caesarean scar and cervical ectopic pregnancies: a single-center experience and literature review. Can Assoc Radiol J 70:307–316 - DOI
    1. Nawroth F, Foth D, Wilhelm L et al (2001) Conservative treatment of ectopic pregnancy in a cesarean section scar with methotrexate: a case report. Eur J Obstet Gynecol Reprod Biol 99(1):135–137 - DOI
    1. Kanat-Pektas M, Bodur S, Dundar O et al (2016) Systematic review: what is the best first-line approach for cesarean section ectopic pregnancy? Taiwan J Obstetr Gynecol 55:263–269 - DOI

Publication types